EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular and Functional Assessment of TSC1 and TSC2 in Individuals with Tuberous Sclerosis Complex

Luiz Gustavo Dufner-Almeida iD, Laís F M Cardozo iD, Mariana R Schwind, Danielly Carvalho, Juliana Paula G Almeida iD, Andrea Maria Cappellano, Thiago G P Alegria, Santoesha Nanhoe, Mark Nellist, Maria Rita Passos-Bueno, Silvana Chiavegatto iD, Nasjla S Silva und 4 weitere

Genes · 03.11.2024 · 15 (11) · 1432

DOI: 10.3390/genes15111432 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Genes, online erschienen am 03.11.2024. Verfasst von Luiz Gustavo Dufner-Almeida und 15 weiteren Autor:innen. Beteiligte Einrichtung: Human Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Instituto de Biociências, Universidade de São Paulo, São…. Hauptthemen laut MEDLINE: Tuberous Sclerosis, Tuberous Sclerosis Complex 2 Protein, Tuberous Sclerosis Complex 1 Protein. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeicoamento de Pessoal de Nível Superior, Fundação de Amparo à Pesquisa do Estado de São Paulo, Tuberous Sclerosis Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tuberous sclerosis complex (TSC) is an autosomal dominant neurodevelopmental disorder and multisystem disease caused by pathogenic DNA alterations in the TSC1 and TSC2 tumor suppressor genes. A molecular genetic diagnosis of TSC confirms the clinical diagnosis, facilitating the implementation of appropriate care and surveillance. TSC1 and TSC2 encode the core components of the TSC1/2 complex (TSC1/2), a negative regulator of the mechanistic target of rapamycin (MTOR) complex 1 (TORC1). Functional analysis of the effects of TSC1 and TSC2 variants on TORC1 activity can help establish variant pathogenicity. We searched for pathogenic alterations to TSC1 and TSC2 in DNA isolated from 116 individuals with a definite clinical diagnosis of TSC. Missense variants and in-frame deletions were functionally assessed. Pathogenic DNA alterations were identified in 106 cases (91%); 18 (17%) in TSC1 and 88 (83%) in TSC2. Of these, 35 were novel. Disruption of TSC1/2 activity was demonstrated for seven TSC2 variants. Molecular diagnostics confirms the clinical diagnosis of TSC in a large proportion of cases. Functional assessment can help establish variant pathogenicity and is a useful adjunct to DNA analysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberous SclerosisTuberous Sclerosis Complex 2 ProteinTuberous Sclerosis Complex 1 ProteinHumansFemaleMaleChildTumor Suppressor ProteinsChild, PreschoolAdultAdolescentMutation, Missense

Stichwörter der Autor:innen

Alu repeatTSC1TSC2missense variantneurodevelopmental disorderpathogenic alterationsplicing varianttuberous sclerosis complex

Substanzen

Tuberous Sclerosis Complex 2 ProteinTuberous Sclerosis Complex 1 ProteinTSC2 protein, humanTSC1 protein, humanTumor Suppressor Proteins

Autor:innen und Institutionen

  • Human Genome and Stem Cell Research Center, Department of Genetics and Evolutionary Biology, Instituto de Biociências, Universidade de São Paulo, São Paulo 05508-090, Brazil.
  • Department of Clinical Genetics, Erasmus Medical Center, 3015 Rotterdam, The Netherlands.
  • Pediatric Neurology Center, Department of Pediatrics, Hospital de Clínicas, Universidade Federal do Paraná, Curitiba 80060-900, Brazil.
  • Division of Neurology, Department of Pediatrics, Santa Casa de Misericórdia, São Paulo 01221-010, Brazil.
  • Grupo de Apoio ao Adolescente e à Criança com Câncer, Instituto de Oncologia Pediátrica, Universidade Federal de São Paulo, São Paulo 04039-001, Brazil.
  • Department of Pharmacology, Instituto de Ciências Biomédicas, Universidade de São Paulo, São Paulo 05508-000, Brazil.

ORCID-Profile: Luiz Gustavo Dufner-Almeida, Laís F M Cardozo, Juliana Paula G Almeida, Silvana Chiavegatto

Förderung

  • Coordenação de Aperfeicoamento de Pessoal de Nível Superior
  • Fundação de Amparo à Pesquisa do Estado de São Paulo
  • Tuberous Sclerosis Association
  • Brazil Ministry of Education
  • Michelle Foundation (The Netherlands)
  • São Paulo Research Foundation/FAPESP
  • CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brasília, Brazil) fellowships
  • TS Alliance

Zitieren

APA

Dufner-Almeida, L. G., Cardozo, L. F. M., Schwind, M. R., Carvalho, D., Almeida, J. P. G., Cappellano, A. M., Alegria, T. G. P., Nanhoe, S., Nellist, M., Passos-Bueno, M. R., Chiavegatto, S., Silva, N. S., Rosemberg, S., Pereira, A. P. A., Antoniuk, S. A., & Haddad, L. A. (2024). Molecular and Functional Assessment of TSC1 and TSC2 in Individuals with Tuberous Sclerosis Complex. Genes, 15(11), 1432. https://doi.org/10.3390/genes15111432

Vancouver

Dufner-Almeida LG, Cardozo LFM, Schwind MR, Carvalho D, Almeida JPG, Cappellano AM, et al. Molecular and Functional Assessment of TSC1 and TSC2 in Individuals with Tuberous Sclerosis Complex. Genes. 2024;15(11):1432. doi:10.3390/genes15111432

BibTeX
@article{DufnerAlmeida2024,
  author = {Dufner-Almeida, Luiz Gustavo and Cardozo, Laís F M and Schwind, Mariana R and Carvalho, Danielly and Almeida, Juliana Paula G and Cappellano, Andrea Maria and Alegria, Thiago G P and Nanhoe, Santoesha and Nellist, Mark and Passos-Bueno, Maria Rita and Chiavegatto, Silvana and Silva, Nasjla S and Rosemberg, Sérgio and Pereira, Ana Paula A and Antoniuk, Sérgio Antônio and Haddad, Luciana A},
  title = {Molecular and Functional Assessment of TSC1 and TSC2 in Individuals with Tuberous Sclerosis Complex},
  journal = {Genes},
  year = {2024},
  volume = {15},
  number = {11},
  pages = {1432},
  doi = {10.3390/genes15111432}
}
Kostenlos starten →